Search research articles
Contact Us
Filters
Showing results (151-160 of 167) with videos related to
Page
of 17
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 25, 2026
Highlights from the 27th European Congress on Gynecological Oncology in Copenhagen: interview compilation of the ENYGO-IJGC editorial fellows
Andrej Cokan, Martina Aida Angeles, Houssein El Hajj, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 25, 2017
Potential Targets' Analysis Reveals Dual PI3K/mTOR Pathway Inhibition as a Promising Therapeutic Strategy for Uterine Leiomyosarcomas-an ENITEC Group Initiative
Tine Cuppens, Daniela Annibali, An Coosemans, et al.
Molecular Cancer
|
September 29, 2014
Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer
Lorena Alonso-Alconada, Laura Muinelo-Romay, Kadri Madissoo, et al.
The Lancet. Oncology
|
July 31, 2025
ESGO-ESTRO-ESP guidelines for the management of patients with endometrial carcinoma: update 2025
Nicole Concin, Xavier Matias-Guiu, David Cibula, et al.
Gynecologic Oncology
|
May 24, 2019
Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data
Paul A Cohen, Aime Powell, Steffen Böhm, et al.
Gynecologic Oncology
|
February 8, 2021
Corrigendum to "Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data" Gynecol. Oncol. 154 (2019) 441-448
Paul A Cohen, Aime Powell, Steffen Böhm, et al.
Gynecologic Oncology
|
February 24, 2020
Corrigendum to "Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data" [Gynecol. Oncol. 154 (2019) 441-448]
Paul A Cohen, Aime Powell, Steffen Böhm, et al.
The Lancet. Oncology
|
May 3, 2024
Prognostic impact and causality of age on oncological outcomes in women with endometrial cancer: a multimethod analysis of the randomised PORTEC-1, PORTEC-2, and PORTEC-3 trials
Famke C Wakkerman, Jiqing Wu, Hein Putter, et al.
NPJ Precision Oncology
|
August 30, 2025
Ex vivo 3D micro-tumour testing platform for predicting clinical response to platinum-based therapy in patients with high-grade serous ovarian cancer
Esmee Koedoot, Dieudonné J van der Meer, Anne M van Altena, et al.
The Prostate
|
August 4, 2018
Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models
Nora M Navone, Wytske M van Weerden, Robert L Vessella, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 167) with videos related to
Sort By:
Page
of 17
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 25, 2026
Highlights from the 27th European Congress on Gynecological Oncology in Copenhagen: interview compilation of the ENYGO-IJGC editorial fellows
Andrej Cokan, Martina Aida Angeles, Houssein El Hajj, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 25, 2017
Potential Targets' Analysis Reveals Dual PI3K/mTOR Pathway Inhibition as a Promising Therapeutic Strategy for Uterine Leiomyosarcomas-an ENITEC Group Initiative
Tine Cuppens, Daniela Annibali, An Coosemans, et al.
Molecular Cancer
|
September 29, 2014
Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer
Lorena Alonso-Alconada, Laura Muinelo-Romay, Kadri Madissoo, et al.
The Lancet. Oncology
|
July 31, 2025
ESGO-ESTRO-ESP guidelines for the management of patients with endometrial carcinoma: update 2025
Nicole Concin, Xavier Matias-Guiu, David Cibula, et al.
Gynecologic Oncology
|
May 24, 2019
Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data
Paul A Cohen, Aime Powell, Steffen Böhm, et al.
Gynecologic Oncology
|
February 8, 2021
Corrigendum to "Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data" Gynecol. Oncol. 154 (2019) 441-448
Paul A Cohen, Aime Powell, Steffen Böhm, et al.
Gynecologic Oncology
|
February 24, 2020
Corrigendum to "Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data" [Gynecol. Oncol. 154 (2019) 441-448]
Paul A Cohen, Aime Powell, Steffen Böhm, et al.
The Lancet. Oncology
|
May 3, 2024
Prognostic impact and causality of age on oncological outcomes in women with endometrial cancer: a multimethod analysis of the randomised PORTEC-1, PORTEC-2, and PORTEC-3 trials
Famke C Wakkerman, Jiqing Wu, Hein Putter, et al.
NPJ Precision Oncology
|
August 30, 2025
Ex vivo 3D micro-tumour testing platform for predicting clinical response to platinum-based therapy in patients with high-grade serous ovarian cancer
Esmee Koedoot, Dieudonné J van der Meer, Anne M van Altena, et al.
The Prostate
|
August 4, 2018
Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models
Nora M Navone, Wytske M van Weerden, Robert L Vessella, et al.
Page
of 17